Lisa Earnhardt Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Lisa Earnhardt.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Lisa Earnhardt. Lisa Earnhardt is an Executive Vice President in ABBOTT LABORATORIES ($ABT) and a Director in KENSEY NASH CORP ($KNSY) and a in Intersect ENT, Inc. ($XENT) and a President and CEO in Intersect ENT, Inc. ($XENT) and a See Remarks in Intersect ENT, Inc. ($XENT) and a Director in NEVRO CORP ($NVRO).
Address: C/O 735 PENNSYLVANIA DRIVE EXTON 19341 PA
Companies in which Lisa Earnhardt is an Insider
ABBOTT LABORATORIES
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Lisa Earnhardt: Executive Vice President
Holdings: 72,946 shares
Current Value: $3,128,654
Latest Transaction: Jun 12 2020
$ABT Market Capitalization: $62.37B
$ABT Previous Close: $42.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Intersect ENT, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Lisa Earnhardt:
Holdings: 431,483 shares
Current Value: $5,803,446
Latest Transaction: Jul 26 2019
$XENT Market Capitalization: $369.90M
$XENT Previous Close: $13.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KENSEY NASH CORP
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Lisa Earnhardt: Director
Holdings: 0 shares
Latest Transaction: Jun 26 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NEVRO CORP
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Lisa Earnhardt: Director
Holdings: 5,303 shares
Current Value: $494,929
Latest Transaction: May 23 2018
$NVRO Market Capitalization: $2.71B
$NVRO Previous Close: $93.33
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Lisa Earnhardt
Sentiment: All, ABT, XENT, KNSY, NVRO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 12 2020 | ABT | ABBOTT LABORATORIE ... | Earnhardt Lisa D | Executive Vice Pres ... | Sell | S | 90.84 | 872 | 79,216 | 72,074 | 72.9 K to 72.1 K (-1.20 %) |
| Jun 12 2020 | ABT | ABBOTT LABORATORIE ... | Earnhardt Lisa D | Executive Vice Pres ... | Payment of Exercise | F | 90.27 | 2,855 | 257,721 | 72,946 | 75.8 K to 72.9 K (-3.77 %) |
| Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Earnhardt Lisa D | Executive Vice Pres ... | Option Exercise | A | 87.72 | 114,940 | 10,082,537 | 114,940 | |
| Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Earnhardt Lisa D | Executive Vice Pres ... | Grant | A | 0.00 | 18,855 | 0 | 75,801 | 56.9 K to 75.8 K (+33.11 %) |
| Jul 26 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | Option Exercise | A | 1.20 | 48,333 | 58,000 | 48,333 | ||
| Jul 26 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | Option Exercise | D | 1.20 | 48,333 | 58,000 | 0 | ||
| Jul 26 2019 | XENT | Intersect ENT, Inc ... | Earnhardt Lisa D | Option Exercise | A | 13.05 | 45,500 | 593,775 | 45,500 |